Where do T cell subsets stand in SARS-CoV-2 infection: an update

Area of Science:

• Immunology
• Virology
• Pathophysiology

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, presents a global health crisis with significant mortality.
• Understanding the intricate interplay between SARS-CoV-2 and the human immune system is vital for developing effective treatments.
• T cells are critical for viral clearance, and their response magnitude correlates inversely with COVID-19 severity.

Purpose of the Study:

• To provide a comprehensive overview of the pathophysiology of COVID-19, focusing on viral mechanisms and host immune responses.
• To elucidate the role of various T cell subtypes in COVID-19 pathogenesis and disease outcome.
• To highlight T cells as potential targets for vaccines and therapies to mitigate COVID-19 severity.

Main Methods:

• This review synthesizes current knowledge on SARS-CoV-2 entry, replication, and cellular pathology.
• It examines the immunological reactions, including systemic and organ-specific presentations of COVID-19.
• The review specifically analyzes the roles of diverse T cell populations, such as Th17, TFH, Treg, γδ T cells, and MAIT cells.

Main Results:

• T cell responses are crucial for controlling SARS-CoV-2 infection.
• Severity of COVID-19 is inversely correlated with the magnitude of the T cell response.
• Specific T cell subtypes, including unconventional populations, may significantly influence disease progression and outcomes.

Conclusions:

• A deeper understanding of SARS-CoV-2 T cell responses is essential for advancing COVID-19 treatment strategies.
• Targeting T cells offers promising avenues for vaccine development and therapeutic interventions.
• Further research into diverse T cell populations is needed to fully comprehend their impact on COVID-19 and to improve patient outcomes.